Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.61 |
| ▸ | IDO1 | P14902 | 1/20 | 0.44 |
| ▸ | AGXT | P21549 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | CA1 | P00915 | 3/20 | 0.42 |
| ▸ | CA2 | P00918 | 3/20 | 0.42 |
| ▸ | CA9 | Q16790 | 3/20 | 0.42 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.42 |
| ▸ | CDK1 | P06493 | 1/20 | 0.42 |
| ▸ | CDK4 | P11802 | 1/20 | 0.42 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.42 |
| ▸ | CCND1 | P24385 | 1/20 | 0.42 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30425720 | 1.00 | TSHR (0.61) | TSHRIDO1AGXTALDH1A1CA1 | |
| SCHEMBL22160794 | 0.98 | TSHR (0.58) | TSHRIDO1AGXTALDH1A1CA1 | |
| Methylene Chloride SCHEMBL29153178 | 0.94 | TSHR (0.54) | TSHRIDO1AGXTALDH1A1CA1 | |
| SCHEMBL2281945 | 0.90 | TSHR (0.54) | TSHRIDO1AGXTALDH1A1CCNB2 | |
| SCHEMBL20216100 | 0.88 | TSHR (0.52) | TSHRIDO1ALDH1A1CCNB2CDK1 | |
| SCHEMBL27172833 | 0.88 | TSHR (0.52) | TSHRIDO1ALDH1A1CCNB2CDK1 | |
| SCHEMBL7924975 | 0.86 | TSHR (0.45) | TSHRALDH1A1CA1CA2CA9 | |
| Acetic Acid SCHEMBL12274807 | 0.86 | ALDH1A1 (0.49) | TSHRALDH1A1MAOBALOX5MAPK1 | |
| SCHEMBL30378670 | 0.85 | L3MBTL1 (0.50) | TSHRL3MBTL1KMT2ATDP1 | |
| SCHEMBL7760105 | 0.84 | TSHR (0.52) | TSHRIDO1AGXTALDH1A1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1705 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12234384-B2 | Adhesion-improving composition for textile material and associated reinforcing textile material | PORCHER INDUSTRIES (FR) | 2025-02-25 | — | — | US | claimed |
| CN-116217480-A | 1,2,3, 4-tetrahydroisoquinoline compound and preparation method and application thereof | 南京工业大学 | 2023-06-06 | — | — | CN | claimed |
| CN-114933620-A | Azithromycin derivatives having epithelial barrier enhancing properties | 艾比恩多制药有限责任公司 | 2022-08-23 | — | — | CN | claimed |
| CN-112135862-B | Composition for improving the adhesion of textile materials and related reinforced textile materials | 博舍工业公司 | 2022-06-03 | — | — | CN | claimed |
| US-20220106349-A1 | Compounds | EPIENDO PHARMACEUTICALS EHF (IS) | 2022-04-07 | — | — | US | claimed |
| US-11236120-B2 | Azithromycin derivatives with epithelial barrier enhancement properties | EPIENDO PHARMACEUTICALS EHF (IS) | 2022-02-01 | — | — | US | claimed |
| US-20210115310-A1 | ADHESION-IMPROVING COMPOSITION FOR TEXTILE MATERIAL AND ASSOCIATED REINFORCING TEXTILE MATERIAL | PORCHER INDUSTRIES (FR) | 2021-04-22 | — | — | US | claimed |
| EP-3784719-A1 | ADHERENCE-IMPROVING COMPOSITION FOR TEXTILE MATERIAL AND ASSOCIATED REINFORCING TEXTILE MATERIAL | Porcher Industries (FR) | 2021-03-03 | — | — | EP | claimed |
| CN-112135862-A | Composition for improving the adhesion of textile materials and related reinforced textile materials | 博舍工业公司 | 2020-12-25 | — | — | CN | claimed |
| US-20200317710-A1 | Azithromycin Derivatives With Epithelial Barrier Enhancement Properties | EPIENDO PHARMACEUTICALS EHF (IS) | 2020-10-08 | — | — | US | claimed |
| WO-2003097609-A1 | N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2003-11-27 | — | — | WO | claimed |
| US-6624331-B1 | Oxidization of 2-benzyloxyethanol using hypochlorous acid in the presence of nitroxy compounds such as 2,2,6,6- tetramethyl piperidinyl-1-oxy, to form chemical intermediates such as benzyloxyacetaldehyde | KURARAY CO., LTD. (JP) | 2003-09-23 | — | — | US | claimed |
| CN-1118464-C | Noval pyrimidine derivatives and process and preparing thereof | YUHAN CORP (KR) | 2003-08-20 | — | — | CN | claimed |
| US-6414160-B1 | REACTING 5-ALKOXY-2(3H)OXAZOLONE COMPOUND WITH ALDEHYDE COMPOUND IN PRESENCE OF LEWIS ACID CATALYST | UBE INDUSTRIES, LTD. (JP) | 2002-07-02 | — | — | US | claimed |
| EP-1170276-A1 | PROCESS FOR THE PREPARATION OF BENZYLOXYACETALDEHYDE | KURARAY CO., LTD. (JP) | 2002-01-09 | — | — | EP | claimed |
| WO-2001002333-A1 | PROCESS FOR PREPARING BENZYLOXYACETALDEHYDE COMPOUNDS | SUMIKA FINE CHEMICALS CO., LTD. (JP) | 2001-01-11 | — | — | WO | claimed |
| EP-1000937-A1 | PROCESS FOR PRODUCING 4-ALKOXYCARBONYL-2-OXAZOLIDINONE COMPOUNDS | UBE INDUSTRIES LIMITED (JP) | 2000-05-17 | — | — | EP | claimed |
| CN-1251586-A | Noval pyrimidine derivatives and process and preparing thereof | YUHAN CORP (KR) | 2000-04-26 | — | — | CN | claimed |
| US-5623081-A | USING BENZYLOXYACETALDEHYDE DIMETHYL ETHER, HALOGENATED 1-PHENYLMETHOXY-4-PENTEN-2-OL; CYCLIZATION | LIN YANG-I (US) | 1997-04-22 | — | — | US | claimed |
| EP-0089487-B1 | NOVEL N,N'-BIS(TRIFLUOROMETHYLSULFONYL)OXAMIDES AND CHEMILUMINESCENT COMPOSITIONS CONTAINING THE SAME | AMERICAN CYANAMID COMPANY (US) | 1987-06-16 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220106349-A1 | Compounds | CFTR, AQP1, CTSA | TSHR 4630/4885IDO1 2095/4885AGXT 3175/4885 |
| US-11236120-B2 | Azithromycin derivatives with epithelial barrier enhancement properties | CFTR, AQP1, CTSA | TSHR 4168/4885IDO1 2078/4885AGXT 3305/4885 |
| US-20200317710-A1 | Azithromycin Derivatives With Epithelial Barrier Enhancement Properties | CFTR, AQP1, CTSA | TSHR 4168/4885IDO1 2078/4885AGXT 3305/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.